3-Carbamoyl-proxyl nitroxide radicals attenuate bleomycin-induced pulmonary fibrosis in mice

Keyphrases

• Bleomycin-induced Pulmonary Fibrosis 100%
• Carbamoyl 100%
• Nitroxide Radical 100%
• Idiopathic Pulmonary Fibrosis 50%
• Lung Fibrosis 50%
• Nitroxide 33%
• Protein Nitration 33%
• Lung Injury 16%
• Poor Prognosis 16%
• Mouse Model 16%
• Disease Severity 16%
• Oxidative Stress 16%
• Antioxidant 16%
• Nitrosative Stress 16%
• Reactive Oxygen Species 16%
• Ovalbumin 16%
• Beneficial Effects 16%
• Weight Loss 16%
• Therapeutic Agents 16%
• Collagen Content 16%
• Disease Pathology 16%
• Airway Inflammation 16%
• Interstitial Lung Disease 16%
• Lung Tissue 16%
• Limited Treatment Options 16%
• Bleomycin 16%
• Lung Function 16%
• Airway Hyperresponsiveness 16%
• Intratracheal 16%
• Reactive Nitrogen Species 16%
• Histological Score 16%
• Prognosis Treatment 16%
• Pathogenic Pathways 16%
• Catalytic Antioxidant 16%
• Acute Asthma 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Nitroxide 100%
• Bleomycin-Induced Pulmonary Fibrosis 100%
• 3 Carbamoyl 2,2,5,5 Tetramethylpyrrolidine 1 Oxyl 100%
• Lung Fibrosis 50%
• Fibrosing Alveolitis 50%
• Disease 33%
• Antioxidant 33%
• Mouse Model 16%
• Reactive Oxygen Metabolite 16%
• Asthma 16%
• Ovalbumin 16%
• Bleomycin 16%
• Respiratory Tract Inflammation 16%
• Respiratory Tract Allergy 16%
• Interstitial Lung Disease 16%
• Reactive Nitrogen Species 16%